ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Top 3 Nutrients to Detox the Liver and Soothe Digestion

Natural Bladder Control, Go Less and Live More

Study bodes well for low-carb eaters

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Omega Fix for Obesity: How the Right Fats Fight Fat

Potential of Quercetin in the Treatment of Melanoma

How Pomegranate May Protect Against Cancer

Trimming the spare tire: Canola oil may cut belly fat

 
Print Page
Email Article

Johns Hopkins 'Memory Bulletin' Comments on Applied NeuroSolutions Alzheimer's Disease Diagnostic

  [ 238 votes ]   [ Discuss This Article ]
www.ProHealth.com • February 18, 2005


VERNON HILLS, Ill.--(BUSINESS WIRE)--Feb. 18, 2005--Applied NeuroSolutions (OTCBB:APNS) (www.appliedneurosolutions.com), headquartered here, said today it was pleased to learn the Johns Hopkins Memory Bulletin has commented on advances being made by APNS in the field of Alzheimer's disease diagnosis in an article entitled "A Spinal Fluid Test For Predicting AD" in its current issue. "Word is beginning to get out about the progress Applied NeuroSolutions is making and, more broadly, about the significance of bringing next generation biological testing to the task of diagnosing Alzheimer's disease" Dr. John DeBernardis, President and CEO, said. "As the technology leader in this emerging field, we are encouraged by the interest of the scientific community and the media." Applied NeuroSolutions, in cooperation with major universities in the Unites States and Europe, has run more than 2500 preclinical cerebrospinal ("CSF") samples with an 85 percent-95 percent sensitivity and specificity. Dr. DeBernardis said that APNS was working closely with the FDA to develop a pathway to bring this CSF test to market, and characterized the attitude of the FDA as "constructive and very supportive." APNS also announced in December 2004 it signed a non-exclusive agreement with bioMerieux, S.A. (Euronext : FR0010096479 - BIM) with the aim of bringing to market on a worldwide basis what is expected to be the first definitive biologic test for the diagnosis of AD. "We encourage interested parties to take a look at this brief article, as well as the numerous peer reviewed publications on our website. We thank Johns Hopkins for their interest in our technology," Dr. DeBernardis said. The Memory Bulletin is a quarterly publication of John Hopkins University that gathers the most current information on preserving memory and coping with Alzheimer's disease and other forms of memory loss at every stage. Over the past decade, Applied NeuroSolutions has worked in cooperation with the Albert Einstein College of Medicine to develop a cerebrospinal fluid (CSF) assay that has consistently identified AD with much greater than 80% sensitivity and specificity in more than 2500 patient samples. This is the level of sensitivity and specificity that has been determined by the Ronald and Nancy Reagan Research Institute of the Alzheimer's Association to be the "industry standard" for AD diagnostics. In addition, the company is developing a blood serum test that would be sensitive and specific enough to also meet this "industry standard." This press release contains forward-looking statements. Applied NeuroSolutions wishes to caution the readers of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, the risks associated with new product development and commercialization, clinical trials, intellectual property, regulatory approvals, potential competitive offerings, and access to capital. For further information, please visit the company's website at www.appliedneurosolutions.com, and review the company's filings with the Securities and Exchange Commission.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Mitochondria Ignite™ with NT Factor® Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Curcumin - a Golden Gift of Nature with Benefits Still Untold Curcumin - a Golden Gift of Nature with Benefits Still Untold
Sleep Like a Baby in Nature's Cradle Sleep Like a Baby in Nature's Cradle
Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract
Stop Bacteria With Nature's Antibiotics Stop Bacteria With Nature's Antibiotics

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map